ES2107525T3 - Peptido trombolitico, su produccion y agente trombolitico. - Google Patents

Peptido trombolitico, su produccion y agente trombolitico.

Info

Publication number
ES2107525T3
ES2107525T3 ES92900924T ES92900924T ES2107525T3 ES 2107525 T3 ES2107525 T3 ES 2107525T3 ES 92900924 T ES92900924 T ES 92900924T ES 92900924 T ES92900924 T ES 92900924T ES 2107525 T3 ES2107525 T3 ES 2107525T3
Authority
ES
Spain
Prior art keywords
peptide
sak
trombolitic
production
waste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900924T
Other languages
English (en)
Inventor
Osamu Matsuo
Masashi Sakai
Kisaku Shimura
Hiroshi Sansawa
Tsunekazu Watanabe
Tsumeo Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of ES2107525T3 publication Critical patent/ES2107525T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

UN PEPTIDO TROMBOLITICO COMPUESTO DE 136 RESIDUOS DEL ACIDO AMINO, EL CUAL TIENE PEQUEÑOS PROBLEMAS DE ANTIGENICIDAD Y ES EFICAZ EN DOSIS SOLAMENTE PEQUEÑAS CUANDO SE COMPARA CON LA ESTAFILOKINASA (SAK). ESTE PEPTIDO ES OBTENIDO POR DESDOBLAMIENTO DE ACIDOS AMINO O DE PEPTIDOS QUE NO AFECTAN A LA ACTIVIDAD DEL SAK POR EL USO DE UNA PROTEASA TRIPSINA. EN PARTICULAR, EL SAK11, EL CUAL ES OBTENIDO POR EL DESDOBLAMIENTO DE UN PEPTIDO COMPUESTO DE DIEZ RESIDUOS DE ACIDO AMINO EN EL TERMINAL N DEL SAK, ES SUPERIOR AL SAK EN LAS ACTIVIDADES DE FIBRINOLISIS, ACTIVACION PLASMINOGENICA, ESPECIFIDAD DE LA FIBRINA, ETC.
ES92900924T 1990-12-17 1991-12-17 Peptido trombolitico, su produccion y agente trombolitico. Expired - Lifetime ES2107525T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP41106390 1990-12-17

Publications (1)

Publication Number Publication Date
ES2107525T3 true ES2107525T3 (es) 1997-12-01

Family

ID=18520124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900924T Expired - Lifetime ES2107525T3 (es) 1990-12-17 1991-12-17 Peptido trombolitico, su produccion y agente trombolitico.

Country Status (11)

Country Link
US (1) US5475089A (es)
EP (1) EP0563385B1 (es)
JP (1) JP2895626B2 (es)
KR (1) KR100221571B1 (es)
AT (1) ATE158613T1 (es)
AU (1) AU665935B2 (es)
CA (1) CA2098588C (es)
DE (1) DE69127757T2 (es)
DK (1) DK0563385T3 (es)
ES (1) ES2107525T3 (es)
WO (1) WO1992011356A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218043B (hu) * 1991-12-30 2000-05-28 Thromb-X N.V., Eljárás szignálpeptid-mentes sztafilokinázok expressziójára
US5951980A (en) * 1995-01-06 1999-09-14 Leuven Research & Development Vzw Identification, production and use of new staphylokinase derivatives with reduced immunogenicity
US6383483B1 (en) * 1995-01-06 2002-05-07 Désiré José Collen Staphylokinase derivatives with cysteine substitutions
CN100342007C (zh) * 2000-01-28 2007-10-10 复旦大学 一种新型重组葡激酶及其制备方法
CN106317193B (zh) * 2015-06-23 2019-07-26 首都医科大学 含Tyr-Val片段的肽,其合成、活性和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337817B2 (en) * 1988-04-14 1998-12-16 Kabushiki Kaisha Yakult Honsha Plasminogen activator and thrombolytic agent
JP2707273B2 (ja) * 1988-04-14 1998-01-28 株式会社ヤクルト本社 血栓溶解剤

Also Published As

Publication number Publication date
CA2098588A1 (en) 1992-06-18
DK0563385T3 (da) 1998-05-04
ATE158613T1 (de) 1997-10-15
KR930703437A (ko) 1993-11-30
US5475089A (en) 1995-12-12
DE69127757T2 (de) 1998-03-12
WO1992011356A1 (en) 1992-07-09
AU9083791A (en) 1992-07-22
EP0563385A4 (en) 1994-07-06
AU665935B2 (en) 1996-01-25
EP0563385A1 (en) 1993-10-06
EP0563385B1 (en) 1997-09-24
KR100221571B1 (ko) 1999-10-01
CA2098588C (en) 2003-08-19
JP2895626B2 (ja) 1999-05-24
DE69127757D1 (de) 1997-10-30

Similar Documents

Publication Publication Date Title
DK105489D0 (da) Polypeptid
AR015977A1 (es) Variantes de proteasa multiplemente substituida con carga neta alterada para su empleo en detergentes
ES2103857T3 (es) Peptidos ciclicos y su uso.
KR900700597A (ko) 신규한 단백질 분해효소 및 세제에 있어서의 사용
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
ES2059547T3 (es) Expresion y secrecion mejoradas de proteinas heterologas en levadura, empleando secuencia conductora de factor alfa truncado.
ATE380875T1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
ATE76900T1 (de) Modifizierter faktor vii/viia.
MX9301751A (es) Acidos amido peroxicarboxilicos.
DE3787460D1 (de) Schimärische peptide für die lieferung von neuropeptiden durch die blut-hirn-grenze.
ES2070322T3 (es) Polipeptidos biologicamente activos basados en las secuencias del factor de crecimiento de transformacion beta.
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
ES2093122T3 (es) Activacion mejorada de proteinas recombinantes.
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
ATE144535T1 (de) Plättchen blockierende peptide
ATE10364T1 (de) Retro-inverso analoga von c-terminalen pentaund hexapeptiden der verbindung p.
ES2133295T3 (es) Peptidos ciclicos y su uso.
ES2107525T3 (es) Peptido trombolitico, su produccion y agente trombolitico.
UA27132C2 (uk) Двофуhкціоhальhі варіаhти урокіhази зі зміцнеhою фібриhолітичhою властивістю і тромбіh-іhгібуючою дією
ATE211765T1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ES2060134T3 (es) Inhibidor de tejido de metaloproteasas (timp-2).
ES2104686T3 (es) Uso de una mezcla de peptidos y aminoacidos en la profilaxis o el tratamiento de la demencia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563385

Country of ref document: ES